bioactive peptides from vegetable proteins

Bioactive peptides from vegetable proteins Mar a Cristina a - PowerPoint PPT Presentation

Bioactive peptides from vegetable proteins Mar a Cristina a Cristina A A n n Mar Centro de Investigacin y Desarrollo en y Desarrollo en Criotecnolog Criotecnolog a a de Alimentos de Alimentos Centro de (CIDCA),

  1. Bioactive peptides from vegetable proteins Marí ía Cristina a Cristina A Añó ñón n Mar Centro de Investigación y Desarrollo en y Desarrollo en Criotecnolog Criotecnologí ía a de Alimentos de Alimentos Centro de (CIDCA), CONICET- - Universidad Nacional de La Plata Universidad Nacional de La Plata (CIDCA), CONICET La Plata, Argentina La Plata, Argentina

  2. Previous research lines Analysis of the relationship between structural - physicochemical characteristics of vegetable proteins, in particular soybean and amaranth proteins, and their functional properties Physical chemical Protein Functional biological structure properties treatments � hydration properties: solubility, WIC, WHC, etc. � capacity to form gels and films. Characterization of matrix gel, rheologial propeties, etc. � foaming and emulsifing capacity. Interfacial and rheological behaviour, stability, etc.

  3. Objective of our research line The main objective of our research line is to evaluate the potentiality of amaranth as a novel source of bioactive compounds, particularly peptides, for using as food ingredients and/or in the development of functional foods .

  4. Amaranth Pseudoceral – Amaranthaceae family Autochthonous from Central America Desirable agricultural properties Seed storage proteins � 15- 17% protein content � well-balanced amino acid composition � Main protein factions: albumins, 11S globulins, P-globulins and prolamins

  5. Amaranth Pseudoceral – Amaranthaceae family Autochthonous from Central America Desirable agricultural properties Seed storage proteins � 15- 17% protein content � well-balanced amino acid composition � Main protein factions: albumins, 11S globulins, P-globulins and prolamins

  6. Antihypertensive activity

  7. ACE – Angiotensin converting enzyme ACE inhibitors inhibitors ACE Regulation of Regulation of captopril, , enalpril,etc enalpril,etc. . captopril blood pressure blood pressure ACE angiotensin I angiotensin II decapeptide octapeptide Vasoconstrictor Vasoconstrictor Avoid bradykinin bradykinin Avoid Increase the the blood blood Increase degradation degradation pressure pressure - vasodilator vasodilator - - -

  8. ACE inhibitory peptides We have identified 154 possible inhibitory peptides in the 11S globulin fraction It is possible to obtain antihypertensive peptides from amaranth storage proteins

  9. Effect of the hydrolysate administration SHRr SHRf 200 200 Fructosa Captopril 1,5 g/kg 10 % v/v Hidrolizado Presión directa media (mmHg) Presión media carotídea (mmHg) 160 150 120 Hidrolizado 100 Control 80 1,8 g/kg 50 40 0 0 0 2 4 6 8 0 8 140 7 Tiempo (horas) Tiempo (horas) The blood pressure decreased in a dose-dependent way as hydrolysate increased. The hypotensive effect was maximal 1.5h after the administration

  10. Possible mechanism In vitro assay Results Isolated aortic smooth muscle + � Peptides act as norepinephrine or a non-competitive norepinephrine antagonist and amaranth hydrolysate � 65% GH shown a vasodilator effect. Contractile responses were recorded

  11. In silico simulation of the interaction between ACE and novel potential peptide inhibitors Molecular modelling of Amaranth 11S globulin IKP LEP Evaluation of exposed surface and IC 50 , candidates Phytochem. 70: 864-870 (2009)


  13. Calculated free energyfor the formation of the ACE-peptide complex Binding Energy of Docked peptides 15 average lowest 10 Free Energy of Binding (kcal/mol) 5 0 -5 -10 VIKP Captopril KP IKP VIKP HVIKP LHVIKP GLHVIKP EGLHVIKP Ki ~ 700 nM 50% electrostatic 50% vdW + hydrophobic + desolvatation Phytochem. 70: 864-870 (2009)

  14. Inhibition of ACE activity Synthetic peptides – in vitro assay captopril Chemical synthesis VIKP ALEP Phytochem. 70: 864-870 (2009 )

  15. Antitumor activity

  16. Inhibition of cell proliferation Different sensitivities P r o l i fe r a ti o n (U M R 1 0 6 ) P r o l i fe r a ti o n (U M R 1 0 6 ) to the API were 1 2 5 ,0 1 2 5 ,0 observed for the four 1 0 0 ,0 1 0 0 ,0 7 5 ,0 7 5 ,0 cell lines. % B a s a l % B a s a l 5 0 ,0 5 0 ,0 2 5 ,0 2 5 ,0 Proteolytic hydrolysis 0 ,0 0 ,0 0 ,0 0 2 ,0 0 4 ,0 0 6 ,0 0 8 ,0 0 1 0 ,0 0 1 2 ,0 0 0 ,0 0 2 ,0 0 4 ,0 0 6 ,0 0 8 ,0 0 1 0 ,0 0 1 2 ,0 0 improved the m g / m l m g / m l inhibitory effect IA M IS IA M IS Cellular lines UMR106 MC3T3-E1 Caco-2 TC7 APIDH30 (IC 50 ) (IC 50 ) (IC 50 ) (IC 50 ) UMR106 [mg/ml] [mg/ml] [mg/ml] [mg/ml] IC50: 0.5 mg/ml API 1.0 ± 0.05 2.5 ± 0.06 1.5 ± 0.1 2.5 ± 0.08 > 25 SPI 10.0 ± 0.1 - - BSA Non inhibition BBI Non inhibition

  17. Changes in cell morphology and cytoskeletal proteins UMR106 UMR106 + API 1mg/ml 24h A partial disorganization The cells exhibited a dense of the actin filaments as nucleus surrounded by a very small well as an alteration in the and highly condensed cytoplasm shape of the cells was after incubation observed

  18. Possible mechanism of cell death Necrosis Apoptosis Flow-cytometry analysis LDH – Necrotic marker After 24h incubation, the API increased the LDH activity increased proportion of apoptotic for API concentrations cells in a dose-dependent higher than 0.5 mg/ml fashion API inhibited cell adhesion in a dose-dependent manner

  19. Conclusions � APIs exhibit anti-hypertensive and a potential antitumor properties. Both effects were enhanced by protease treatment. � In “in vitro” experiments we have demonstrated an important effect of the amaranth hydrolysates as inhibitors of ACE. We have also identified using in silico simulation two novel tetrapetides encrypted exclusively in amaranth 11S globulin with high power to inhibit ACE. � We also detect a significant effect in lowering blood pressure in rats that we suspect is primarily due to peripheral vasodilatation. We assume that the amaranth hydrolysates would be acting at the level of the local Renin-angiotensin-system.

  20. � The mechanism of action of the antiproliferative activity appears to involve an inhibition of cell proliferation and cell adhesion along with the production of cell damage resulting in a permanent loss of cell viability. The processes of apoptosis and necrosis might be involved in the mechanism of cell death. � Cytostatic and cytotoxic effects exerted by the API on tumor cells would point to its use as a potential ingredient in functional food in order to decrease the risk of human diseases such as cancer, or even prevent such pathology altogether.

  21. Argentine groups working in functional foods � CERELA - CONICET – NUTucuman. - Application of lactic bacteria in functional food formulation, - Food design and novel dietary supplements using starters and lactic probiotic, - Peptide production and isoflavone bioconversion, - Characterization of active peptides, - Conjugated linoleic acid production , - Biopolymer production and hydrolysis of allergenic proteins � School of Exact Sciences and School of Pharmacy and Biochemistry – UBA – Bs.As. – Different nutrition aspects of carbohydrates, vitamins, minerals, etc. – Vegetable processing and use of waste. Formulation of functional foods. � NU Comahue – Neuquen – Process design for the production of functional foods based on fruits

  22. � NU Rio Negro – Viedma – Bioactive ingredients for food development � NU Quilmes – Quilmes, Pcia. Bs.As. - Multi-components obtaining from soybean and yeast as potential functional foods ingredients � NU Córdoba – Córdoba - Physicochemical and functional properties of baking products � CIDCA – CONICET – NU La Plata – La Plata, Pcia. Bs.As – Development of jams with fiber addition, - Dairy functional foods, - Encapsulation of bioactive compounds, - Bioactive peptides from vegetable proteins � INTA � INTI

  23. CIDCA (UNLP-CONICET) Thank you for your attention Calle 47 y 116 – La Plata, Pcia. Bs.As. María Cristina Añón

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.


More recommend